Reuters: Hot Stocks: UPDATE 1-Dynavax sinks on discounted offering, CEO exit

Reuters: Hot Stocks Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Dynavax sinks on discounted offering, CEO exit May 9th 2012, 15:13 Wed May 9, 2012 11:13am EDT May 9 (Reuters) - Shares of Dynavax Technologies Corp , which priced its public offering at a steep discount, fell as much as 22 percent a day after the biopharmaceutical company said its chief executive intends to step down. Dynavax priced its public offering of 17.5 million shares at $4.25 each, a 17 percent discount to Tuesday's close, and said it plans to use the net proceeds for the anticipated launch of its experimental hepatitis B vaccine. The company, which intends to independently launch the vaccine Heplisav in the United States, said on Tuesday it will begin looking for a successor to Chief Executive Dino Dina. Dynavax had filed a marketing application with the U.S. Food and Drug Administration in April for the vaccine in adults aged 18 to 70 years. Shares of the company fell 21 percent to $4 in morning trade on Wednesday on the Nasdaq.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions